UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 145

Sortiert nach

Nivolumab in sorafenib-naive and sorafenib-experienced patients with advanced hepatocellular carcinoma: 5-year follow-up from CheckMate 040

Annals of oncology, 2024-04, Vol.35 (4), p.381-391

2024

Volltextzugriff (PDF)

A randomized, placebo-controlled phase 2 study of ganitumab or conatumumab in combination with FOLFIRI for second-line treatment of mutant KRAS metastatic colorectal cancer

Annals of oncology, 2013-07, Vol.24 (7), p.1777-1785

2013

Volltextzugriff (PDF)

Primary diffuse large B-cell lymphoma of the breast: prognostic factors and outcomes of a study by the International Extranodal Lymphoma Study Group

Annals of oncology, 2008-02, Vol.19 (2), p.233-241

2008

Volltextzugriff (PDF)

Travel warning with capecitabine

Annals of oncology, 2009-07, Vol.20 (7), p.1281-1281

2009

Volltextzugriff (PDF)

Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with intermediate and advanced/relapsed hepatocellular carcinoma: a TOS–ESMO initiative endorsed by CSCO, ISMPO, JSMO, KSMO, MOS and SSO

Annals of oncology, 2020-03, Vol.31 (3), p.334-351

2020

Volltextzugriff (PDF)

A Phase 1 dose-finding and pharmacodynamic study of rapamycin in combination with bevacizumab in patients with unresectable hepatocellular carcinoma

European journal of cancer (1990), 2013-03, Vol.49 (5), p.999-1008

2013

Volltextzugriff (PDF)

Comparing the efficacy of sunitinib with sorafenib in xenograft models of human hepatocellular carcinoma: mechanistic explanation

Current cancer drug targets, 2011-10, Vol.11 (8), p.944

2011

Volltextzugriff (PDF)

A phase Ib study of selumetinib (AZD6244, ARRY-142886) in combination with sorafenib in advanced hepatocellular carcinoma (HCC)

Annals of oncology, 2016-12, Vol.27 (12), p.2210-2215

2016

Volltextzugriff (PDF)

Engineering Styrene Oxide Isomerase Towards Enhanced Chemoenzymatic Synthesis of (S)‐Flurbiprofen

Advanced synthesis & catalysis, 2024-07, Vol.366 (13), p.2967-2975

2024

Volltextzugriff (PDF)

High‐Level Production of Phenylacetaldehyde using Fusion‐Tagged Styrene Oxide Isomerase

Advanced synthesis & catalysis, 2021-03, Vol.363 (6), p.1714-1721

2021

Volltextzugriff (PDF)

Response to multi-targeted kinase inhibitor (MKI) after immune checkpoint inhibitor (ICI) in patients with hepatocellular carcinoma (HCC)

Annals of oncology, 2018-11, Vol.29, p.ix57-ix58

2018

Volltextzugriff (PDF)

Phase I study: Safety and tolerability of varlitinib (VAR) in combination with oxaliplatin and capecitabine (COX) or oxaliplatin and 5-FU (FOL) in advanced solid tumours

Annals of oncology, 2018-10, Vol.29 Suppl 8, p.viii141

2018

Volltextzugriff (PDF)

Locoregional therapy in hepatocellular carcinoma: when to start and when to stop and when to revisit

ESMO open, 2021-06, Vol.6 (3), p.100129-100129, Article 100129

2021

Volltextzugriff (PDF)

Has COVID-19 had a greater impact on female than male oncologists? Results of the ESMO Women for Oncology (W4O) Survey

ESMO open, 2021-06, Vol.6 (3), p.100131-100131, Article 100131

2021

Volltextzugriff (PDF)

Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with prostate cancer

ESMO open, 2022-08, Vol.7 (4), p.100518, Article 100518

2022

Volltextzugriff (PDF)

A phase Ib study of selumetinib (AZD6244, ARRY-142886) in combination with sorafenib in advanced hepatocellular carcinoma (HCC)

Annals of oncology, 2018-02, Vol.29 (2), p.526-526

2018

Volltextzugriff (PDF)

Female leadership in oncology—has progress stalled? Data from the ESMO W4O authorship and monitoring studies

ESMO open, 2021-12, Vol.6 (6), p.100281-100281, Article 100281

2021

Volltextzugriff (PDF)

Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with renal cell carcinoma

ESMO open, 2021-12, Vol.6 (6), p.100304-100304, Article 100304

2021

Volltextzugriff (PDF)

Challenges in oncology career: are we closing the gender gap? Results of the new ESMO Women for Oncology Committee survey

ESMO open, 2023-04, Vol.8 (2), p.100781-100781, Article 100781

2023

Volltextzugriff (PDF)

P-121Phase Ib trial of oxaliplatin, UGT1A1 genotype-directed dosing of irinotecan and chronomodulated capecitabine (OXIRI) chemotherapy in patients with advanced pancreatic cancer

Annals of oncology, 2016-06, Vol.27 (suppl_2), p.ii35-ii36

2016

Volltextzugriff (PDF)

Safety and preliminary efficacy of nivolumab (nivo) in patients (pts) with advanced hepatocellular carcinoma (aHCC): Interim analysis of the phase 1/2 CheckMate-040 study

Annals of oncology, 2016-10, Vol.27, p.vi209-vi209

2016

Volltextzugriff (PDF)

Nivolumab in sorafenib-experienced patients with advanced hepatocellular carcinoma (HCC) with or without chronic viral hepatitis: CheckMate 040 study

Journal of hepatology, 2017, Vol.66 (1), p.S34-S35

2017

Volltextzugriff (PDF)

Sunitinib (SUTENT, SU11248) suppresses tumor growth and induces apoptosis in xenograft models of human hepatocellular carcinoma

Current cancer drug targets, 2009-09, Vol.9 (6), p.738

2009

Volltextzugriff (PDF)

P-334 Transcriptomic patterns in early-secretory and mid-secretory endometrium in a natural menstrual cycle immediately before in vitro fertilization and embryo transfer

Human reproduction (Oxford), 2023-06, Vol.38 (Supplement_1)

2023

Volltextzugriff (PDF)

Dietary Excesses of Leucine Influence Growth and Body Composition of Rainbow Trout

The Journal of nutrition, 1991-12, Vol.121 (12), p.1932-1939

1991

Volltextzugriff (PDF)

1 – 25 von 145

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(114)
Mit Volltextzugriff
(128)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(81)
Life Sciences & Biomedicine
(62)
Humans
(52)
Male
(31)
Female
(29)
Oncology
(21)
Biological And Medical Sciences
(20)
Middle Aged
(20)
Adult
(18)
Aged
(16)
Medical Sciences
(13)
Technology
(12)
Physical Sciences
(10)
Treatment Outcome
(10)
Retrospective Studies
(9)
Chemistry
(8)
Aged, 80 And Over
(7)
Animals
(7)
Fundamental And Applied Biological Sciences. Psychology
(7)
General & Internal Medicine
(7)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Nivolumab in sorafenib-naive and sorafenib-experienced patients with advanced hepatocellular carcinoma: 5-year follow-up from CheckMate 040

A randomized, placebo-controlled phase 2 study of ganitumab or conatumumab in combination with FOLFIRI for second-line treatment of mutant KRAS metastatic colorectal cancer

Primary diffuse large B-cell lymphoma of the breast: prognostic factors and outcomes of a study by the International Extranodal Lymphoma Study Group

Travel warning with capecitabine

Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with intermediate and advanced/relapsed hepatocellular carcinoma: a TOS–ESMO initiative endorsed by CSCO, ISMPO, JSMO, KSMO, MOS and SSO

A Phase 1 dose-finding and pharmacodynamic study of rapamycin in combination with bevacizumab in patients with unresectable hepatocellular carcinoma

Comparing the efficacy of sunitinib with sorafenib in xenograft models of human hepatocellular carcinoma: mechanistic explanation

A phase Ib study of selumetinib (AZD6244, ARRY-142886) in combination with sorafenib in advanced hepatocellular carcinoma (HCC)

Engineering Styrene Oxide Isomerase Towards Enhanced Chemoenzymatic Synthesis of (S)‐Flurbiprofen

High‐Level Production of Phenylacetaldehyde using Fusion‐Tagged Styrene Oxide Isomerase

Response to multi-targeted kinase inhibitor (MKI) after immune checkpoint inhibitor (ICI) in patients with hepatocellular carcinoma (HCC)

Phase I study: Safety and tolerability of varlitinib (VAR) in combination with oxaliplatin and capecitabine (COX) or oxaliplatin and 5-FU (FOL) in advanced solid tumours

Locoregional therapy in hepatocellular carcinoma: when to start and when to stop and when to revisit

Has COVID-19 had a greater impact on female than male oncologists? Results of the ESMO Women for Oncology (W4O) Survey

Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with prostate cancer

A phase Ib study of selumetinib (AZD6244, ARRY-142886) in combination with sorafenib in advanced hepatocellular carcinoma (HCC)

Female leadership in oncology—has progress stalled? Data from the ESMO W4O authorship and monitoring studies

Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with renal cell carcinoma

Challenges in oncology career: are we closing the gender gap? Results of the new ESMO Women for Oncology Committee survey

P-121Phase Ib trial of oxaliplatin, UGT1A1 genotype-directed dosing of irinotecan and chronomodulated capecitabine (OXIRI) chemotherapy in patients with advanced pancreatic cancer

Safety and preliminary efficacy of nivolumab (nivo) in patients (pts) with advanced hepatocellular carcinoma (aHCC): Interim analysis of the phase 1/2 CheckMate-040 study

Nivolumab in sorafenib-experienced patients with advanced hepatocellular carcinoma (HCC) with or without chronic viral hepatitis: CheckMate 040 study

Sunitinib (SUTENT, SU11248) suppresses tumor growth and induces apoptosis in xenograft models of human hepatocellular carcinoma

P-334 Transcriptomic patterns in early-secretory and mid-secretory endometrium in a natural menstrual cycle immediately before in vitro fertilization and embryo transfer

Dietary Excesses of Leucine Influence Growth and Body Composition of Rainbow Trout

Suchergebnisse filtern